Costs of Inflamatory Bowel Disease (Crohns Disease and Ulcerative Colitis) In Serbia

Abstract

The most prevalent symptoms at baseline were abdominal pain (85.3%), constipation (7.5%) and bloating (76.5%). Mean IBS-QoL was 61.8±18.2 (scale: 0-100 [worst-best]). Mean EQ-5D was 58.4±20.2 (scale: 0-100 [worst-best]) and 85.3% and 50.9% of patients reported moderate-to-severe problems in pain/discomfort and anxiety/depression, respectively. Over the year, 78.4% patients consulted a primary care physician and 69.6% a gastroenterologist, 18.6% patients required emergency department visits/hospitalisation and 66.7% had a diagnostic test. 54.9% patients took prescription drugs for their IBS-C and 69.6% took non-prescription drugs. Mean (95%CI) annual direct costs per patient for Germany's national healthcare system:

Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data

“…With regards to presenteeism, we were only able to identify three studies, one conducted in Poland [14], one in Hungary [1] and one in Israel [2]. Four studies assessed total productivity loss, two in The Netherlands [15, 19], one in Serbia [22] and one in Poland [14]. Both presenteeism and productivity losses reported cost per patient year, in USD dollars converted to 2017 base year.…”

“…Total productivity losses were reported in four studies, one in Poland [14], one in Serbia [22] and two in the Netherlands [15, 19], as shown in Table 6. The proportion of indirect costs associated to total UC costs4 was reported in two studies, conducted in the Netherlands and by the same author.…”

“…1567 $ per patient year). This difference can be explained by the under-utilization of biologic therapy and low health services prices used by IBD patients in Serbia [22].…”